🌍 A new study led by @FelixJTeufel, @CBulstra and @mkali_windad offers a new perspective on tackling the global diabetes crisis, inspired by the HIV response! Learn more about how these strategies can be applied to diabetes: https://t.co/D52KxS43BV
New—Enhancing global access to #diabetes medicines: policy lessons from the #HIV response https://t.co/uKm0O0OBf0 #globalhealth#FREE to read with registration (also FREE)
“The Commission will have access to an
extensive dataset, arguably one of the largest in the
world, pertaining to health and poverty alleviation.”
👀 @HarvardChanCHP@HarvardHSI
📝 https://t.co/1138YXgtKH
Join us Wed 13 Dec 13th (9:00AM-1:00PM BRT/7:00AM-11:00AM EST) for the event:
Health Systems and Cancer Initiative-Latin America: Scaling-Up High-Value Health Services for Cancer: Challenges and Opportunities
Register via https://t.co/WtK2oMiXZx receive the webinar link.
Today we visited @Ebserh_Gov to learn more about the Brazilian health system and integration of the federal university hospitals. A huge undertaking with significant challenges and opportunities. Thank you to the team for hosting us! #HealthSystems @RifatAtun
Delighted to see our analysis of global cancer research funding published today: Global funding for cancer research between 2016 and 2020: a content analysis of public and philanthropic investments - ScienceDirect https://t.co/8U15v7w3zH
Join the 1st International Symposium on Digital Transformation in the SUS online on 2-3 Oct w/ Prof. @RifatAtun and Prof. @Adriano_Massuda!
Register via https://t.co/ltcoBDPbfd.
📣 Join us virtually or in-person TOMORROW AT 12PM for our next seminar presentation by Caroline Bulstra DVM Phd (@CBulstra).
💻 REGISTER: https://t.co/pAz4XQfRMv
Our September issue is now live!
It features trials in NSCLC, serous tubo-ovarian cancer, breast cancer, and glioma, studies on paediatric care in LMICs, reviews on paediatric care, radiotherapy in Latin America, and accelerated approvals, and much more.
https://t.co/w5aMWwOWSL
On the cover, a study assesses the efficacy and safety of semaglutide 50 mg for the treatment of overweight or obesity in adults without type 2 diabetes.
Find this and more in our latest issue: https://t.co/g85NvTeSGK
2021-22 saw fast change.
The GSF transitioned from the UN to a Swiss Foundation. From expanding our team, to establishing our governance, to testing SURGfund - we have grown quickly.
Thanks to our partners & team: together we have made huge strides.
Read our report below.
New publication in @JAMA_current w/ HPACC @RifatAtun & colleagues.
Worldwide, aspirin is underused in secondary #prevention of #cardiovasculardisease events, particularly in low-income countries.
Read this and other recent publications: https://t.co/2aqeYfAvQD.
#healthsystems
To fight the next pandemics we have to fight the current ones. To fight all pandemics we have to fight inequality. To win the fight we have to join together. This coming week comes a new boost as leaders from different fields join together in that struggle. More news to come…
What can we learn from the Silicon Valley approach to medicine? Rohin Francis @MedCrisis looks at the oppportunities and potential pitfalls. Read more: https://t.co/SEWH360SMv
Released now! Integration of noncommunicable diseases into HIV service packages: technical brief to support country needs into proposal for International funding. Integration of noncommunicable diseases into HIV service packages: technical brief (https://t.co/GZWml0uJTm)